Items where authors include "Lawrence, C."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
O’Neill, J.R. orcid.org/0000-0001-8664-8825, Jameson, A. orcid.org/0000-0002-3248-2302, McLean, S.L. orcid.org/0000-0001-9328-8928 et al. (3 more authors) (2024) A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature. Journal of Psychopharmacology, 38 (4). 344 -352. ISSN 0269-8811
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Scott, F. orcid.org/0000-0002-8689-2905, Marsh, J. orcid.org/0000-0001-6192-6198, Murris, K. orcid.org/0000-0001-9613-7738 et al. (12 more authors) (2023) An ecological perspective on children’s play with digital technologies in South Africa and the United Kingdom. International Journal of Play, 12 (3). 2235466. pp. 349-374. ISSN 2159-4937
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Poole, A.P., Finnis, M.E., Anstey, J. et al. (106 more authors) (2022) The effect of a liberal approach to glucose control in critically ill patients with type 2 diabetes: a multicenter, parallel-group, open-label randomized clinical trial. American Journal of Respiratory and Critical Care Medicine, 206 (7). pp. 874-882. ISSN 1073-449X
Murris, K. orcid.org/0000-0001-9613-7738, Scott, F. orcid.org/0000-0002-8689-2905, Stjerne Thomsen, B. orcid.org/0000-0002-9292-6534 et al. (4 more authors) (2022) Researching digital inequalities in children’s play with technology in South Africa. Learning, Media and Technology, 48 (3). pp. 542-555. ISSN 1743-9884
Schmid, P., Zaiss, M., Harper-Wynne, C. et al. (29 more authors) (2019) Fulvestrant plus vistusertib vs fulvestrant plus everolimus vs fulvestrant alone for women with hormone receptor–positive metastatic breast cancer: the MANTA phase 2 randomized clinical trial. JAMA Oncology, 5 (11). pp. 1556-1564. ISSN 2374-2445
Berndt, S.I., Camp, N.J., Skibola, C.F. et al. (123 more authors) (2016) Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nature Communications, 7. 10933. ISSN 2041-1723
Berndt, S.I., Skibola, C.F., Joseph, V. et al. (127 more authors) (2013) Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nature Genetics, 45 (8). pp. 868-876. ISSN 1061-4036